Idexx Laboratories (IDXX) 91.67 $IDXX
Idexx Laboratories Shares Up 24.6% Since SmarTrend's Buy Recommendation (IDXX)
Comtex SmarTrend(R) - Thu Jun 09, 1:45PM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 4 months, Idexx Laboratories has returned 24.58% as of today's recent price of $89.41.
IDXX: 91.67 (+1.63)
IDEXX Launches New Rapid Pregnancy Test for Cattle
PR Newswire - Tue Jun 07, 6:30AM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today the launch of the Rapid Visual Pregnancy Test for cattle, a point-of-care test that can detect an open cow 28 days post-breeding, improving reproductive efficiency and profitability. With the new test, veterinarians can more quickly and accurately identify open cows using whole blood samples collected before the farm visit, enabling veterinarians to provide value-added medical consulting services while on farm.
IDXX: 91.67 (+1.63)
IDEXX Laboratories to Present at William Blair 36th Annual Growth Stock Conference
PR Newswire - Mon Jun 06, 2:00PM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the William Blair 36th Annual Growth Stock Conference. Jonathan W. Ayers, Chairman and Chief Executive Officer, is scheduled to make a presentation on the Company on Tuesday, June 14, 2016 at 11:30 a.m. (Central Time), at the Four Seasons Hotel, Chicago, Illinois. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archive of the presentation will be available via the same link.
IDXX: 91.67 (+1.63)
22.9% Return Seen to Date on SmarTrend Idexx Laboratories Call (IDXX)
Comtex SmarTrend(R) - Thu Jun 02, 1:11AM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 3 months, Idexx Laboratories has returned 22.86% as of today's recent price of $88.18.
IDXX: 91.67 (+1.63)
nLife Therapeutics appoints Dr. Errol B. De Souza as Executive Chairman
GlobeNewswire - Wed Jun 01, 4:11AM CDT
nLife Therapeutics, an early-stage biopharmaceutical company leading developments in conjugated nucleic acids as therapeutic agents for central nervous system (CNS) and neuromuscular (NS) disorders, today announced the appointment of Dr. Errol B. De Souza, Ph.D. as executive chairman.
NBIX: 44.59 (+1.86), TRGT: 0.96 (-1.25), CBIO: 1.42 (-0.03), PTN: 0.48 (+0.01), IDXX: 91.67 (+1.63), BIOD: 0.31 (-0.02)
SmarTrend Watching for Potential Rebound in Shares of Idexx Laboratories After 1.87% Loss
Comtex SmarTrend(R) - Tue May 31, 3:37PM CDT
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $88.30 to a high of $90.48. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $89.42 on volume of 453,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IDXX: 91.67 (+1.63)
IDEXX Laboratories: Strong Instrument Placement Drives Q1
Zacks Equity Research - Zacks Investment Research - Mon May 30, 7:12AM CDT
IDEXX (IDXX) started off 2016 on a strong note, with its first-quarter results squarely beating the Zacks Consensus Estimate.
BSX: 22.97 (+0.31), SRDX: 24.06 (+0.71), BAX: 45.96 (+1.02), IDXX: 91.67 (+1.63)
Why Investors Still See Value in Alkermes, AMAG Pharmaceuticals, IDEXX Laboratories and Atossa Genetics?
PR Newswire - Thu May 19, 7:50AM CDT
The equities market is never short of surprises, and one sector that is always abounding of surprises is without doubt the Healthcare space. ActiveWallSt.com has uncovered four stocks in the Healthcare sector ahead of today's trading session: Alkermes PLC (NASDAQ: ALKS), AMAG Pharmaceuticals Inc. (NASDAQ: AMAG), IDEXX Laboratories Inc. (NASDAQ: IDXX), and Atossa Genetics Inc. (NASDAQ: ATOS). Sign up for your complimentary alerts at:
ATOS: 0.29 (-0.03), AMAG: 24.89 (+0.43), IDXX: 91.67 (+1.63), ALKS: 43.75 (+0.71)
Look for Shares of Idexx Laboratories to Potentially Pullback after Yesterday's 1.33% Rise
Comtex SmarTrend(R) - Mon May 16, 3:09PM CDT
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $86.97 to a high of $88.03. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $87.87 on volume of 439,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 91.67 (+1.63)
Idexx Laboratories Up 21.9% Since SmarTrend Uptrend Call (IDXX)
Comtex SmarTrend(R) - Tue May 10, 1:55PM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 3 months, Idexx Laboratories has returned 21.89% as of today's recent price of $87.48.
IDXX: 91.67 (+1.63)
SmarTrend Watching for Potential Pullback in Shares of Idexx Laboratories After 1.01% Gain
Comtex SmarTrend(R) - Mon May 02, 3:34PM CDT
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $84.35 to a high of $85.43. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $84.50 on volume of 477,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 91.67 (+1.63)
IDEXX Laboratories, Inc. Sees More Growth Ahead
Lee Samaha, The Motley Fool - Motley Fool - Mon May 02, 7:47AM CDT
and its management cheered the market by doing something few companies have done in the current earnings season: raise full-year guidance, generate double-digit organic revenue growth, and talk of more favorable end markets. In a moderately growing...
IDXX: 91.67 (+1.63)
IDEXX Laboratories (IDXX) Tops Q1 Earnings; Lifts '16 View
Zacks Equity Research - Zacks Investment Research - Mon May 02, 7:42AM CDT
IDEXX (IDXX) started off 2016 on a strong note; with its first-quarter results squarely beating the Zacks Consensus Estimate.
BSX: 22.97 (+0.31), BAX: 45.96 (+1.02), IDXX: 91.67 (+1.63), OFIX: 44.22 (-0.11)
Idexx beats Street 1Q forecasts
Automated Insights - Fri Apr 29, 6:23AM CDT
WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported first-quarter profit of $46 million.
IDXX: 91.67 (+1.63)
IDEXX Laboratories Announces First Quarter Results
PR Newswire - Fri Apr 29, 6:00AM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) today reported revenues for the first quarter of 2016 of $418 million, an increase of 9% compared to the prior year period. Organic revenue growth for the quarter was 11%, supported by strong growth in the Companion Animal Group ("CAG"
and Water segments.
IDXX: 91.67 (+1.63)
Thermo Fisher (TMO) Beats on Q1 Earnings, Raises Outlook
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 9:14AM CDT
Thermo Fisher Scientific, Inc.'s (TMO) first-quarter 2016 adjusted earnings per share (EPS) came in at $1.80, 3.4% ahead of the Zacks Consensus Estimate.
TMO: 152.14 (+2.29), EW: 99.08 (+1.04), IDXX: 91.67 (+1.63), HOLX: 35.62 (+1.51)
IDEXX Laboratories to Release 2016 First Quarter Financial Results
PR Newswire - Tue Apr 12, 3:03PM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2016 first quarter financial results for Friday, April 29, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
IDXX: 91.67 (+1.63)
IDEXX: Strong Q4 Raises Hope amid Bleak Currency Scenario
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 1:30PM CDT
On Mar 9, 2015, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).
ABMD: 104.25 (+2.55), EW: 99.08 (+1.04), IDXX: 91.67 (+1.63), CRY: 11.94 (+0.09)
Idexx Laboratories Shares Up 24.6% Since SmarTrend's Buy Recommendation (IDXX)
Comtex SmarTrend(R) - Thu Jun 09, 1:45PM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 4 months, Idexx Laboratories has returned 24.58% as of today's recent price of $89.41.
IDXX: 91.67 (+1.63)
IDEXX Launches New Rapid Pregnancy Test for Cattle
PR Newswire - Tue Jun 07, 6:30AM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today the launch of the Rapid Visual Pregnancy Test for cattle, a point-of-care test that can detect an open cow 28 days post-breeding, improving reproductive efficiency and profitability. With the new test, veterinarians can more quickly and accurately identify open cows using whole blood samples collected before the farm visit, enabling veterinarians to provide value-added medical consulting services while on farm.
IDXX: 91.67 (+1.63)
IDEXX Laboratories to Present at William Blair 36th Annual Growth Stock Conference
PR Newswire - Mon Jun 06, 2:00PM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) announced today that it will participate in the William Blair 36th Annual Growth Stock Conference. Jonathan W. Ayers, Chairman and Chief Executive Officer, is scheduled to make a presentation on the Company on Tuesday, June 14, 2016 at 11:30 a.m. (Central Time), at the Four Seasons Hotel, Chicago, Illinois. Individuals can access the live audio webcast of the presentation through a link on the home page of the IDEXX Laboratories website, www.idexx.com. An archive of the presentation will be available via the same link.
IDXX: 91.67 (+1.63)
22.9% Return Seen to Date on SmarTrend Idexx Laboratories Call (IDXX)
Comtex SmarTrend(R) - Thu Jun 02, 1:11AM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 3 months, Idexx Laboratories has returned 22.86% as of today's recent price of $88.18.
IDXX: 91.67 (+1.63)
nLife Therapeutics appoints Dr. Errol B. De Souza as Executive Chairman
GlobeNewswire - Wed Jun 01, 4:11AM CDT
nLife Therapeutics, an early-stage biopharmaceutical company leading developments in conjugated nucleic acids as therapeutic agents for central nervous system (CNS) and neuromuscular (NS) disorders, today announced the appointment of Dr. Errol B. De Souza, Ph.D. as executive chairman.
NBIX: 44.59 (+1.86), TRGT: 0.96 (-1.25), CBIO: 1.42 (-0.03), PTN: 0.48 (+0.01), IDXX: 91.67 (+1.63), BIOD: 0.31 (-0.02)
SmarTrend Watching for Potential Rebound in Shares of Idexx Laboratories After 1.87% Loss
Comtex SmarTrend(R) - Tue May 31, 3:37PM CDT
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $88.30 to a high of $90.48. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $89.42 on volume of 453,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
IDXX: 91.67 (+1.63)
IDEXX Laboratories: Strong Instrument Placement Drives Q1
Zacks Equity Research - Zacks Investment Research - Mon May 30, 7:12AM CDT
IDEXX (IDXX) started off 2016 on a strong note, with its first-quarter results squarely beating the Zacks Consensus Estimate.
BSX: 22.97 (+0.31), SRDX: 24.06 (+0.71), BAX: 45.96 (+1.02), IDXX: 91.67 (+1.63)
Why Investors Still See Value in Alkermes, AMAG Pharmaceuticals, IDEXX Laboratories and Atossa Genetics?
PR Newswire - Thu May 19, 7:50AM CDT
The equities market is never short of surprises, and one sector that is always abounding of surprises is without doubt the Healthcare space. ActiveWallSt.com has uncovered four stocks in the Healthcare sector ahead of today's trading session: Alkermes PLC (NASDAQ: ALKS), AMAG Pharmaceuticals Inc. (NASDAQ: AMAG), IDEXX Laboratories Inc. (NASDAQ: IDXX), and Atossa Genetics Inc. (NASDAQ: ATOS). Sign up for your complimentary alerts at:
ATOS: 0.29 (-0.03), AMAG: 24.89 (+0.43), IDXX: 91.67 (+1.63), ALKS: 43.75 (+0.71)
Look for Shares of Idexx Laboratories to Potentially Pullback after Yesterday's 1.33% Rise
Comtex SmarTrend(R) - Mon May 16, 3:09PM CDT
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $86.97 to a high of $88.03. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $87.87 on volume of 439,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 91.67 (+1.63)
Idexx Laboratories Up 21.9% Since SmarTrend Uptrend Call (IDXX)
Comtex SmarTrend(R) - Tue May 10, 1:55PM CDT
SmarTrend identified an Uptrend for Idexx Laboratories (NASDAQ:IDXX) on February 22nd, 2016 at $71.77. In approximately 3 months, Idexx Laboratories has returned 21.89% as of today's recent price of $87.48.
IDXX: 91.67 (+1.63)
SmarTrend Watching for Potential Pullback in Shares of Idexx Laboratories After 1.01% Gain
Comtex SmarTrend(R) - Mon May 02, 3:34PM CDT
Idexx Laboratories (NASDAQ:IDXX) traded in a range yesterday that spanned from a low of $84.35 to a high of $85.43. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $84.50 on volume of 477,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
IDXX: 91.67 (+1.63)
IDEXX Laboratories, Inc. Sees More Growth Ahead
Lee Samaha, The Motley Fool - Motley Fool - Mon May 02, 7:47AM CDT
and its management cheered the market by doing something few companies have done in the current earnings season: raise full-year guidance, generate double-digit organic revenue growth, and talk of more favorable end markets. In a moderately growing...
IDXX: 91.67 (+1.63)
IDEXX Laboratories (IDXX) Tops Q1 Earnings; Lifts '16 View
Zacks Equity Research - Zacks Investment Research - Mon May 02, 7:42AM CDT
IDEXX (IDXX) started off 2016 on a strong note; with its first-quarter results squarely beating the Zacks Consensus Estimate.
BSX: 22.97 (+0.31), BAX: 45.96 (+1.02), IDXX: 91.67 (+1.63), OFIX: 44.22 (-0.11)
Idexx beats Street 1Q forecasts
Automated Insights - Fri Apr 29, 6:23AM CDT
WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Friday reported first-quarter profit of $46 million.
IDXX: 91.67 (+1.63)
IDEXX Laboratories Announces First Quarter Results
PR Newswire - Fri Apr 29, 6:00AM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) today reported revenues for the first quarter of 2016 of $418 million, an increase of 9% compared to the prior year period. Organic revenue growth for the quarter was 11%, supported by strong growth in the Companion Animal Group ("CAG"
and Water segments. IDXX: 91.67 (+1.63)
Thermo Fisher (TMO) Beats on Q1 Earnings, Raises Outlook
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 9:14AM CDT
Thermo Fisher Scientific, Inc.'s (TMO) first-quarter 2016 adjusted earnings per share (EPS) came in at $1.80, 3.4% ahead of the Zacks Consensus Estimate.
TMO: 152.14 (+2.29), EW: 99.08 (+1.04), IDXX: 91.67 (+1.63), HOLX: 35.62 (+1.51)
IDEXX Laboratories to Release 2016 First Quarter Financial Results
PR Newswire - Tue Apr 12, 3:03PM CDT
IDEXX Laboratories, Inc. (NASDAQ: IDXX) has scheduled the release of its 2016 first quarter financial results for Friday, April 29, at approximately 7:00 a.m. ET. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
IDXX: 91.67 (+1.63)
IDEXX: Strong Q4 Raises Hope amid Bleak Currency Scenario
Zacks Equity Research - Zacks Investment Research - Tue Mar 15, 1:30PM CDT
On Mar 9, 2015, we issued an updated research report on IDEXX Laboratories, Inc. (IDXX).
ABMD: 104.25 (+2.55), EW: 99.08 (+1.04), IDXX: 91.67 (+1.63), CRY: 11.94 (+0.09)
